Manganese–Fluorouracil Metallodrug Nanotheranostic for MRI-Correlated Drug Release and Enhanced Chemoradiotherapy

Chan Yang,Guosheng Song,Haifeng Yuan,Yue Yang,Yuqi Wang,Deju Ye,Hongmin Meng,Shuangyan Huan,Xiao-Bing Zhang

DOI: https://doi.org/10.31635/ccschem.020.202000188

2021-01-01

CCS Chemistry

Abstract:For cancer therapy, drug delivery systems are often limited by insufficient drug loading capacity, which usually results in systemic toxicity and heavy metabolic burden to excrete the carriers. Herein, we reported a "one-pot" method for constructing metal (Mn2+)-fluorouracil (FU)-coordinated nanotheranostics (Mn-FU) by self-assembly of FU (as bridging ligands) and Mn2+ (as metal nodes) through Mn-N/O coordination interactions. Importantly, owing to the effective coordination between Mn and FU, Mn-FU exhibits high drug loading efficacy (47.7 wt %), encapsulation efficacy (82.6%), and relatively large yield (1 g/pot). In acidic tumor microenvironments, efficient release of FU and Mn2+ is realized because of nitrogen protonation. The released FU and Mn2+ from Mn-FU are used for chemotherapy and turn on magnetic resonance imaging (MRI), respectively, achieving MRI-correlated drug release. After PEG modification, Mn-FU displays high tumor homing ability via enhanced permeability and retention effects and quick renal clearance owing to the disassembly in acidic biological conditions. As a result, Mn-FU substantially enhances the synergistic effects of chemoradiotherapy. Meanwhile, the systemic toxic side effects of free FU-based chemoradiotherapy were greatly reduced through this nanotheranostic. Our strategy offers a facile way to construct metallodrug nanotheranostics for efficient cancer theranostics.